Financial Performance - The company expects a net profit attributable to shareholders of the parent company for 2024 to be between 90 million and 105 million yuan, marking a turnaround from a loss in the previous year [3]. - The net profit after deducting non-recurring gains and losses is projected to be between 106 million and 121 million yuan, also indicating a recovery compared to the previous year [5]. - In the previous year, the company reported a net loss of 75.48 million yuan attributable to shareholders of the parent company [7]. Operational Strategy - The company achieved significant contract wins during 2023, contributing to a solid order backlog that supports the expected profit recovery in 2024 [10]. - The company is implementing a "Four Excellence" strategy to enhance quality and safety, ensuring stable execution of existing orders [10]. - The company aims to improve its management efficiency and profitability through lean production and digital transformation initiatives [10]. - The company has successfully executed existing orders, which has led to a turnaround in profitability for 2024 [11]. Forecast Accuracy - There are no uncertainties affecting the accuracy of the profit forecast [12]. - The forecast data is preliminary and subject to final audited results in the 2024 annual report [13].
博迈科(603727) - 2024 Q4 - 年度业绩预告(更正)